A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia	Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute myeloid leukemia, bone marrow disorder, chronic myelomonocytic leukemia, hematologic disorder, leukemia, myelodysplastic syndrome, myelodysplastic/myeloproliferative disease, myeloid leukemia, neoplasm	Active, not recruiting	Phase 3	2025-03-20		NCT05883956

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Otsuka Australia Pharmaceutical Pty Ltd	1

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Adelaide Oncology and Haematology	North Adelaide	Australia	1
Auckland City Hospital	Grafton	New Zealand	3
Calvary Mater Newcastle	Newcastle	Australia	2
Christchurch Hospital	Christchurch	New Zealand	19
Dunedin Hospital	Dunedin	New Zealand	7
Grampian Health (Ballarat Base Hospital)	Ballarat Central	Australia	1
Latrobe Regional Hospital	Traralgon	Australia	2
North Shore Hospital (Waitemata District Health Board)	Takapuna	New Zealand	1
Pindara Private Hospital	Benowa	Australia	2
Townsville Hospital	Townsville	Australia	2
Waikato Hospital	Hamilton	New Zealand	15